Non-small cell lung cancers (NSCLC) have a collective reputation for not responding very well to chemotherapy. Researchers now report a means of evaluating an immunotherapy that fights off NSCLC by strengthening a patient’s own immune system….
FDG PET evaluates immunotherapy for non-small cell lung cancer
Non-small cell lung cancers (NSCLC) have a collective reputation for not responding very well to chemotherapy. Researchers now report a means of evaluating an immunotherapy that fights off NSCLC by strengthening a patient’s own immune system….